- Page 1: Research Report 2010MAX DELBRÜCK C
- Page 5 and 6: Mechanisms of Hypertension-Induced
- Page 7: Function and Dysfunction of the Ner
- Page 12 and 13: That barrier is now falling thanks
- Page 14: protein MACC1 as a marker for metas
- Page 17 and 18: cical trials) and technology platfo
- Page 19 and 20: science.” This location will perm
- Page 21: A detailed proposal for the DZHK ha
- Page 24 and 25: fall; the 2009 session lasted two w
- Page 27 and 28: Cardiovascular andMetabolic Disease
- Page 29 and 30: Our research activities are organiz
- Page 31 and 32: combined computation and laboratory
- Page 33 and 34: Helena Emich*Esther Kur*Daniel Mili
- Page 35 and 36: Previously, we demonstrated that so
- Page 37 and 38: SHH. In line with these findings ex
- Page 39 and 40: Burcu SimsekRalf MeißnerTechnical
- Page 41 and 42: Figure 4. Effect of adipocyte-condi
- Page 43 and 44: Martin Liss*Brian Anderson**Technic
- Page 45 and 46: Transformation of the flat heart fi
- Page 47 and 48: Left panel: in vivo imaging of bloo
- Page 49 and 50: Stepwise specification of pancreati
- Page 51 and 52: TCF/Lef signaling in the kidney. On
- Page 53 and 54:
Pinar Oenal*Marlon StoeckiusNadine
- Page 55 and 56:
Figure 3. Proof of principle: FACS
- Page 57 and 58:
Graduate StudentsSamreen FalakJudit
- Page 59 and 60:
Mineralocorticoid receptorAnette Fi
- Page 61 and 62:
arrhythmia and sudden cardiac death
- Page 63 and 64:
Daumke (both MDC) on studying the (
- Page 65 and 66:
Graduate StudentsPhilipp DuBoisSant
- Page 67 and 68:
the prevention and treatment. The s
- Page 69 and 70:
Graduate StudentsFlorian KirchnerMa
- Page 71 and 72:
vated receptors (PPARs) are target
- Page 73 and 74:
Christof Thalhammer (as of 11/09)Se
- Page 75 and 76:
Dr. AlexanderKrivokharchenkoDr. Iri
- Page 77 and 78:
ing constructs, which express small
- Page 79 and 80:
have identified an “active” cop
- Page 81 and 82:
Figure 1. Study designFigure 2. Ass
- Page 83 and 84:
The principle standard SILAC (left)
- Page 85 and 86:
Technical AssistantAndrea Katzer**
- Page 87 and 88:
SecretariatSonja GieringPetra Haink
- Page 89:
PAR-CLIP (Photoactivatable-Ribonucl
- Page 92 and 93:
Cancer Research ProgramKrebsforschu
- Page 94 and 95:
(metastasis-associated in colon can
- Page 96 and 97:
In the lab of Achim Leutz, the tran
- Page 98 and 99:
chromatin. These results identify s
- Page 100 and 101:
another transcription factor, KorA,
- Page 102 and 103:
mice with large non-immunogenic tum
- Page 104 and 105:
Signaling Pathways, Cell Biology, a
- Page 106 and 107:
Figure 2. Mutual requirements for E
- Page 108 and 109:
Walter BirchmeierStructure of the G
- Page 110 and 111:
The tyrosine phosphatase Shp2 direc
- Page 112 and 113:
Daniel Besser(Delbrück Fellow)Stru
- Page 114 and 115:
Structure of the GroupUlrike Ziebol
- Page 116 and 117:
Achim LeutzStructure of the GroupGr
- Page 118 and 119:
type but not in C/EBP deficient or
- Page 120 and 121:
Structure of the GroupFrank Rosenba
- Page 122 and 123:
Peter M. SchlagStructure of the Gro
- Page 124 and 125:
protein-protein interactions. We fo
- Page 126 and 127:
Structure of the GroupClemens A. Sc
- Page 128 and 129:
Structure of the GroupGroup LeaderD
- Page 130 and 131:
Figure 2. Processing of N-linked gl
- Page 132 and 133:
Structure of the GroupHarald Saumwe
- Page 134 and 135:
Structural and Functional GenomicsS
- Page 136 and 137:
Figure 2. Crystal structure of the
- Page 138 and 139:
Structure of the GroupOliver Daumke
- Page 140 and 141:
Structure of the GroupChristof Tann
- Page 142 and 143:
Tumor ImmunologyMartin LippStructur
- Page 144 and 145:
A novel animal model to study the r
- Page 146 and 147:
Structure of the GroupGroup LeaderP
- Page 148 and 149:
Thomas BlankensteinStructure of the
- Page 150 and 151:
Structure of the GroupGroup LeaderP
- Page 152 and 153:
Bernd DörkenStructure of the Group
- Page 154 and 155:
ABGene deregulation and its impact
- Page 156 and 157:
Structure of the GroupAntonio Pezzu
- Page 158 and 159:
Structure of the GroupPeter DanielG
- Page 160 and 161:
Kirsten Falk andOlaf RötzschkeStru
- Page 162 and 163:
Structure of the GroupIduna Fichtne
- Page 164 and 165:
Figure 22a2b2a: Dual liposomes sign
- Page 167 and 168:
Function and Dysfunctionof the Nerv
- Page 169 and 170:
Photo: David Ausserhofer / Copyrigh
- Page 171 and 172:
epithelium of the stria vascularis
- Page 173 and 174:
capsaicin, the active component of
- Page 175 and 176:
logical process. They recently show
- Page 177 and 178:
Dr. Katja Grossmann*Dr. Elena Rocca
- Page 179 and 180:
Figure 3. Myoblast fusion in mice r
- Page 181 and 182:
Dr. Rubén Vicente García*Dr. Stef
- Page 183 and 184:
Determinants of anion-proton coupli
- Page 185 and 186:
PhD studentsJadwiga CholewaRogerio
- Page 187 and 188:
Selected PublicationsSchmidt, H., S
- Page 189 and 190:
Graduate StudentsYinth Andrea Berna
- Page 191 and 192:
distinct developmental mechanisms a
- Page 193 and 194:
Applications of the tethered toxin
- Page 195 and 196:
A B CD E FRNA editing emerges as a
- Page 197 and 198:
CaCC in olfactory receptor neurones
- Page 199 and 200:
Current ResearchI remain fascinated
- Page 201 and 202:
Figure 1. (a) Anatomical reconstruc
- Page 203 and 204:
Dr. Jan-Leo RinnenthalHelena Radbru
- Page 205 and 206:
Graduate StudentsLarisa BulavinaBru
- Page 207 and 208:
Figure 3. Oligodendrocytic coupling
- Page 209 and 210:
Dr. Pablo Porras-MillanDr. Ellen Ra
- Page 211 and 212:
Project Management (GO-Bio)Dr. Anne
- Page 213:
on-pathway or off-pathway to amyloi
- Page 216 and 217:
Berlin Institute for Medical System
- Page 218 and 219:
Markus Landthaler is an outstanding
- Page 220 and 221:
Wei ChenStructure of the GroupGroup
- Page 222 and 223:
Stefan KempaStructure of the GroupG
- Page 224 and 225:
Structure of the GroupChristoph Die
- Page 227 and 228:
The Experimental andClinical Resear
- Page 229 and 230:
Photo: David Ausserhofer / Copyrigh
- Page 231 and 232:
eases (with a special focus on mult
- Page 233 and 234:
Kardiovaskuläre Forschung, DZHK) a
- Page 235 and 236:
Graduate StudentsJoanna SchneiderSi
- Page 237 and 238:
Associated scientists and clinical
- Page 239 and 240:
Dr. André RudolphDr. med. Dipl.-Ph
- Page 241:
Epoxyeicosatrienoic acids (EETs) an
- Page 244 and 245:
Miguel AndradeStructure of the Grou
- Page 246 and 247:
Martin FalckeStructure of the Group
- Page 248 and 249:
Structure of the GroupGroup LeaderD
- Page 250 and 251:
Structure of the GroupGroup LeaderD
- Page 252 and 253:
Structure of the GroupGroup LeaderH
- Page 254 and 255:
Structure of the GroupGroup LeaderD
- Page 256 and 257:
Structure of the GroupGroup LeaderD
- Page 259 and 260:
AcademicsAkademische Aktivitäten
- Page 261 and 262:
eplication and reprogramming of the
- Page 263 and 264:
2009Physician Professor Walter Rose
- Page 265 and 266:
AwardsPreise20082009Martin Bergmann
- Page 267 and 268:
International PhD ProgramInternatio
- Page 269 and 270:
iological systems. All the particip
- Page 271 and 272:
07-08 November 7. Bucher Hämatolog
- Page 273 and 274:
Speaker Institute TitleMagdalena G
- Page 275 and 276:
Speaker Institute TitleAlbrecht Str
- Page 277 and 278:
Speaker Institute TitleSergey Kaspa
- Page 279 and 280:
OverviewÜberblick
- Page 281 and 282:
asis for funding decisions made by
- Page 283 and 284:
was founded by the Max Delbrück Ce
- Page 286 and 287:
Organizational StructureOrganisatio
- Page 288 and 289:
Scientific CommitteeThe Scientific
- Page 290 and 291:
Dr. Zsuzsanna IzsvákProf. Dr. Thom
- Page 292 and 293:
Facts and FiguresFakten und Kennzah
- Page 294 and 295:
Extramural funding in 2008 (in thou
- Page 296 and 297:
National Genome Research Network (N
- Page 298 and 299:
Organisation chart of the Max-Delbr
- Page 300 and 301:
274 IndexIndexAAbdelilah-Seyfried,
- Page 302 and 303:
276 IndexElse, L. . . . . . . . . .
- Page 304 and 305:
278 IndexJia, S. . . . . . . . . .
- Page 306 and 307:
280 IndexMeyer, S. . . . . . . . .
- Page 308 and 309:
282 IndexSSaar, K. . . . . . . . .
- Page 310:
284 IndexVoigt, B. . . . . . . . .
- Page 313 and 314:
Common FacilitiesA 8 Gate House wit